The Organisation of Pharmaceutical Producers of India (OPPI) has elected Suresh Pattathil as its next President today. The term is for two years and is effective from September 26, 2022. Suresh takes over from S Sridhar, MD Pfizer India Limited, who has been with the association since 2021. 

Suresh Pattathil is the Managing Director and General Manager, Allergan, an AbbVie Company, a dynamic biopharmaceutical company, which discovers and delivers innovative medicines and solutions that address complex health issues and enhance people’s lives. He is responsible for commercial operations in India & South Asia markets. With more than 30 years of experience in the pharmaceutical industry, Suresh has held several senior management positions in companies such as Pfizer, Schering Plough, MSD and Ferring. 

Speaking on his appointment, Pattathil shared, “I am honoured to take this responsibility at this critical juncture for healthcare in the country. Health today has become a priority for the government, and OPPI, as an association, focused on research and innovation, is working towards solving some of the most pressing healthcare needs. I look forward to making a difference to patients and the industry as OPPI works with the government to enable healthcare access. I thank the members of OPPI’s Executive Committee who selected me for this role.”